Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01501539 · ClinicalTrials.gov registry record · NA
Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement
A NA study of Soft Tissue Inflammation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
- 1
- Study location
NCT01501539 is a NA study of Soft Tissue Inflammation that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 171 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01501539, a NA study of Soft Tissue Inflammation, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.
Conditions Studied
Interventions
- PROCEDURE Standard Hydrocolloid Dressing
- PROCEDURE Silver Hydrocolloid Dressing
Study Locations (1)
Illinois
- Children's Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01501539
The ClinicalTrials.gov registry entry for NCT01501539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Soft Tissue Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Standard Hydrocolloid Dressing is the first listed.
NCT01501539 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01501539 about?
NCT01501539 is a clinical study titled "Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement". The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.
What is the current status of trial NCT01501539?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2010-12. Estimated completion is 2017-06.
What conditions does trial NCT01501539 study?
This clinical trial studies the following conditions: Soft Tissue Inflammation.
What interventions are being tested in trial NCT01501539?
The interventions under investigation include: Standard Hydrocolloid Dressing (PROCEDURE), Silver Hydrocolloid Dressing (PROCEDURE).
Who is sponsoring clinical trial NCT01501539?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01501539 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.